92 related articles for article (PubMed ID: 38659927)
21. Interaction of human HelQ with DNA polymerase delta halts DNA synthesis and stimulates DNA single-strand annealing.
He L; Lever R; Cubbon A; Tehseen M; Jenkins T; Nottingham AO; Horton A; Betts H; Fisher M; Hamdan SM; Soultanas P; Bolt EL
Nucleic Acids Res; 2023 Feb; 51(4):1740-1749. PubMed ID: 36718939
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment.
Jackson LM; Moldovan GL
NAR Cancer; 2022 Dec; 4(4):zcac042. PubMed ID: 36568963
[TBL] [Abstract][Full Text] [Related]
23. Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling.
Thakar T; Dhoonmoon A; Straka J; Schleicher EM; Nicolae CM; Moldovan GL
Nat Commun; 2022 Sep; 13(1):5323. PubMed ID: 36085347
[TBL] [Abstract][Full Text] [Related]
24. The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1.
Dhoonmoon A; Nicolae CM; Moldovan GL
Nat Commun; 2022 Aug; 13(1):5063. PubMed ID: 36030235
[TBL] [Abstract][Full Text] [Related]
25. Division of Labor by the HELQ, BLM, and FANCM Helicases during Homologous Recombination Repair in
Thomas A; Cox J; Wolfe KB; Mingalone CH; Yaspan HR; McVey M
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328029
[TBL] [Abstract][Full Text] [Related]
26. Platinum-based drugs for cancer therapy and anti-tumor strategies.
Zhang C; Xu C; Gao X; Yao Q
Theranostics; 2022; 12(5):2115-2132. PubMed ID: 35265202
[TBL] [Abstract][Full Text] [Related]
27. HELQ is a dual-function DSB repair enzyme modulated by RPA and RAD51.
Anand R; Buechelmaier E; Belan O; Newton M; Vancevska A; Kaczmarczyk A; Takaki T; Rueda DS; Powell SN; Boulton SJ
Nature; 2022 Jan; 601(7892):268-273. PubMed ID: 34937945
[TBL] [Abstract][Full Text] [Related]
28. RAD52: Paradigm of Synthetic Lethality and New Developments.
Rossi MJ; DiDomenico SF; Patel M; Mazin AV
Front Genet; 2021; 12():780293. PubMed ID: 34887904
[TBL] [Abstract][Full Text] [Related]
29. Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells.
Jackson LM; Dhoonmoon A; Hale A; Dennis KA; Schleicher EM; Nicolae CM; Moldovan GL
Nucleic Acids Res; 2021 Dec; 49(22):12855-12869. PubMed ID: 34871431
[TBL] [Abstract][Full Text] [Related]
30. BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage.
Kang Z; Fu P; Alcivar AL; Fu H; Redon C; Foo TK; Zuo Y; Ye C; Baxley R; Madireddy A; Buisson R; Bielinsky AK; Zou L; Shen Z; Aladjem MI; Xia B
Nat Commun; 2021 Oct; 12(1):5966. PubMed ID: 34645815
[TBL] [Abstract][Full Text] [Related]
31. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.
Tirman S; Quinet A; Wood M; Meroni A; Cybulla E; Jackson J; Pegoraro S; Simoneau A; Zou L; Vindigni A
Mol Cell; 2021 Oct; 81(19):4026-4040.e8. PubMed ID: 34624216
[TBL] [Abstract][Full Text] [Related]
32. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
[TBL] [Abstract][Full Text] [Related]
33. Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".
Cantor SB
DNA Repair (Amst); 2021 Nov; 107():103209. PubMed ID: 34419699
[TBL] [Abstract][Full Text] [Related]
34. The
Simoneau A; Xiong R; Zou L
Genes Dev; 2021 Sep; 35(17-18):1271-1289. PubMed ID: 34385259
[TBL] [Abstract][Full Text] [Related]
35. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
Mol Cell; 2021 Aug; 81(15):3227. PubMed ID: 34358459
[No Abstract] [Full Text] [Related]
36. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
[TBL] [Abstract][Full Text] [Related]
37. The emerging determinants of replication fork stability.
Thakar T; Moldovan GL
Nucleic Acids Res; 2021 Jul; 49(13):7224-7238. PubMed ID: 33978751
[TBL] [Abstract][Full Text] [Related]
38. To skip or not to skip: choosing repriming to tolerate DNA damage.
Quinet A; Tirman S; Cybulla E; Meroni A; Vindigni A
Mol Cell; 2021 Feb; 81(4):649-658. PubMed ID: 33515486
[TBL] [Abstract][Full Text] [Related]
39. Replication Gaps Underlie BRCA Deficiency and Therapy Response.
Panzarino NJ; Krais JJ; Cong K; Peng M; Mosqueda M; Nayak SU; Bond SM; Calvo JA; Doshi MB; Bere M; Ou J; Deng B; Zhu LJ; Johnson N; Cantor SB
Cancer Res; 2021 Mar; 81(5):1388-1397. PubMed ID: 33184108
[TBL] [Abstract][Full Text] [Related]
40. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
